SECT 505(b)(2) stands for various terms. Discover the full forms, meanings, and possible interpretations of SECT 505(b)(2) across different fields and industries.
A document whereby a pharmaceutical manufacturer or its agent requests permission from the United States Food and Drug Administration (FDA) for a license to market a drug for one or more specified indications; besides a chemical and pharmacologic description of the drug, the application must show the results of clinical trials conducted with respect to the indication for which a license is requested.
AdministrationAnalysisAssociationAstronomyBiotechnologyControlFdaGovernmentLaboratoryMedicalScienceScientific & EducationalUSLast updated: